CD44 and cancer: EMMPRIN is also involved in drug resistance, as it enhances the synthesis of hyaluronan, which then forms a protective cap around cancer cells and inhibits the entry of chemotherapeutic drugs, and due to EMMPRIN interaction with CD44 that activates the PI3K signalling pathway and induces survival genes (53, 54).